|
3-[[((1R,2R)-2-(1-哌啶基)环己基]氨基]-4-[[4-(三氟甲基)苯基]氨基]-3-环丁烯-1,2-二酮
|
R281561-50mg
|
≥98%,≥99%(ee) |
1211565-08-0 |
50mg
|
¥ 311.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(+)-2-(α-(异丁基)甲胺)-1H-苯并咪唑
|
R281547-500mg
|
≥98% |
1235960-36-7 |
500mg
|
¥ 2060.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-(+)-2-(α-(异丁基)甲胺)-1H-苯并咪唑
|
R281547-100mg
|
≥98% |
1235960-36-7 |
100mg
|
¥ 515.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-(+)-2-(α-甲基甲胺)-1H-苯并咪唑
|
R281543-1g
|
≥98% |
163959-79-3 |
1g
|
¥ 2102.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-(+)-2-(α-甲基甲胺)-1H-苯并咪唑
|
R281543-250mg
|
≥98% |
163959-79-3 |
250mg
|
¥ 701.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4R,4''R)-2,2''-(1-苯基丙烷-2,2-二基)双(4,5,5-三苯基-4,5-二氢恶唑)
|
R281537-100mg
|
≥98% |
2409652-69-1 |
100mg
|
¥ 879.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4R,4''R)-2,2''-(1-苯基丙烷-2,2-二基)双(4,5,5-三苯基-4,5-二氢恶唑)
|
R281537-25mg
|
≥98% |
2409652-69-1 |
25mg
|
¥ 528.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基噁唑]
|
R281536-100mg
|
≥98% |
1656253-81-4 |
100mg
|
¥ 449.9
|
现货 |
|
0 |
阿拉丁 |
|
(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基噁唑]
|
R281536-25mg
|
≥98% |
1656253-81-4 |
25mg
|
¥ 129.9
|
现货 |
|
0 |
阿拉丁 |
|
1-[(4R)-4-叔丁基-4,5-二氢-2-恶唑基]异喹啉
|
R281530-100mg
|
≥98%,≥99%(ee) |
1402851-53-9 |
100mg
|
¥ 148.9
|
现货 |
|
0 |
阿拉丁 |
|
1-[(4R)-4-叔丁基-4,5-二氢-2-恶唑基]异喹啉
|
R281530-25mg
|
≥98%,≥99%(ee) |
1402851-53-9 |
25mg
|
¥ 59.9
|
现货 |
|
0 |
阿拉丁 |
|
2-[(4R)-4-叔丁基-4,5-二氢-2-恶唑基]吡啶
|
R281526-100mg
|
≥95% |
242482-28-6 |
100mg
|
¥ 111.9
|
现货 |
|
0 |
阿拉丁 |
|
2-[(4R)-4-叔丁基-4,5-二氢-2-恶唑基]吡啶
|
R281526-25mg
|
≥95% |
242482-28-6 |
25mg
|
¥ 75.9
|
现货 |
|
0 |
阿拉丁 |
|
[(1R,2R)-2-羟基环己基]氨基甲酸苯甲基酯
|
R281523-5g
|
≥98% |
134108-76-2 |
5g
|
¥ 1731.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[(1R,2R)-2-羟基环己基]氨基甲酸苯甲基酯
|
R281523-1g
|
≥98% |
134108-76-2 |
1g
|
¥ 559.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-4-异丙基-2-恶唑烷硫酮
|
R281507-2g
|
≥98% |
1217463-35-8 |
2g
|
¥ 2400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(R)-4-异丙基-2-恶唑烷硫酮
|
R281507-500mg
|
≥98% |
1217463-35-8 |
500mg
|
¥ 1000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2R)-2-氨基-3-甲基-N-2-吡啶基丁酰胺
|
R281498-500mg
|
≥98% |
1568043-19-5 |
500mg
|
¥ 988.9
|
现货 |
|
0 |
阿拉丁 |
|
(2R)-2-氨基-3-甲基-N-2-吡啶基丁酰胺
|
R281498-100mg
|
≥98% |
1568043-19-5 |
100mg
|
¥ 268.9
|
现货 |
|
0 |
阿拉丁 |
|
(1'R,2'R,3aS,3“aS,8aR,8”aR)-(+)-3,3“,3a,3”a,8,8“,8a,8”a-八氢双螺{2H-茚并[1,2-d]噁唑-2,1'-环己烷-2',2“-[2H]茚并[1,2-d]噁唑}
|
R281494-1g
|
≥97% |
947515-50-6 |
1g
|
¥ 3899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1'R,2'R,3aS,3“aS,8aR,8”aR)-(+)-3,3“,3a,3”a,8,8“,8a,8”a-八氢双螺{2H-茚并[1,2-d]噁唑-2,1'-环己烷-2',2“-[2H]茚并[1,2-d]噁唑}
|
R281494-250mg
|
≥97% |
947515-50-6 |
250mg
|
¥ 1299.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,2R)-(-)-1,2-双(4-羟苯基)乙二胺二盐酸盐
|
R281462-500mg
|
≥98% |
1055301-14-8 |
500mg
|
¥ 2960.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,2R)-(-)-1,2-双(4-羟苯基)乙二胺二盐酸盐
|
R281462-100mg
|
≥98% |
1055301-14-8 |
100mg
|
¥ 740.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1R,2R)-(+)-1,2-双(4-二甲基氨基苯基)乙二胺四盐酸盐
|
R281460-500mg
|
≥98% |
866267-84-7 |
500mg
|
¥ 4038.9
|
期货,请咨询 |
|
0 |
阿拉丁 |